DekaBank Deutsche Girozentrale Boosts Stake in Healthcare Realty Trust Incorporated (NYSE:HR)

DekaBank Deutsche Girozentrale boosted its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR) by 2.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 308,198 shares of the real estate investment trust’s stock after buying an additional 7,431 shares during the period. DekaBank Deutsche Girozentrale owned 0.08% of Healthcare Realty Trust worth $5,120,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Muzinich & Co. Inc. lifted its holdings in Healthcare Realty Trust by 98.1% during the fourth quarter. Muzinich & Co. Inc. now owns 2,179 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 1,079 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Healthcare Realty Trust by 38.1% during the second quarter. Allspring Global Investments Holdings LLC now owns 2,276 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 628 shares during the period. Quarry LP purchased a new stake in Healthcare Realty Trust during the fourth quarter worth $39,000. Principal Securities Inc. purchased a new stake in shares of Healthcare Realty Trust during the 4th quarter valued at $45,000. Finally, Creekmur Asset Management LLC purchased a new stake in shares of Healthcare Realty Trust during the 4th quarter valued at $85,000.

Analysts Set New Price Targets

Several brokerages have recently commented on HR. Wedbush increased their price objective on Healthcare Realty Trust from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Wells Fargo & Company lowered Healthcare Realty Trust from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $17.00 to $16.00 in a report on Tuesday, July 30th. Finally, Scotiabank increased their price objective on Healthcare Realty Trust from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Healthcare Realty Trust has an average rating of “Hold” and an average target price of $17.00.

Insiders Place Their Bets

In other Healthcare Realty Trust news, Director John Knox Singleton bought 6,500 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were purchased at an average cost of $18.24 per share, for a total transaction of $118,560.00. Following the transaction, the director now directly owns 57,082 shares of the company’s stock, valued at $1,041,175.68. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 9,000 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $156,510.00. Following the transaction, the director now directly owns 22,252 shares of the company’s stock, valued at $386,962.28. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director John Knox Singleton bought 6,500 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were acquired at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the transaction, the director now directly owns 57,082 shares in the company, valued at $1,041,175.68. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 15,728 shares of company stock valued at $279,069. Company insiders own 0.56% of the company’s stock.

Healthcare Realty Trust Stock Performance

Shares of HR opened at $18.19 on Wednesday. The business’s 50-day moving average is $17.75 and its two-hundred day moving average is $15.97. The company has a market capitalization of $6.89 billion, a P/E ratio of -13.68 and a beta of 0.91. Healthcare Realty Trust Incorporated has a fifty-two week low of $12.77 and a fifty-two week high of $18.90.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Friday, August 2nd. The real estate investment trust reported ($0.39) earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.77). The company had revenue of $316.30 million for the quarter, compared to analyst estimates of $317.90 million. Healthcare Realty Trust had a negative return on equity of 8.50% and a negative net margin of 42.79%. Healthcare Realty Trust’s revenue for the quarter was down 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.39 earnings per share. Analysts forecast that Healthcare Realty Trust Incorporated will post 1.56 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 28th. Shareholders of record on Monday, August 12th were given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 6.82%. The ex-dividend date was Monday, August 12th. Healthcare Realty Trust’s dividend payout ratio is currently -93.23%.

Healthcare Realty Trust Profile

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.